Novo Nordisk Braces for Potential Tariff Impacts Amidst Trump’s Threats

In a recent statement, Novo Nordisk's CEO has addressed concerns regarding the potential re-emergence of tariffs under the Trump administration, reiterating the company’s preparedness for any economic fluctuations that may arise. This announcement comes in light of previous tariffs imposed that had significant implications for pharmaceutical businesses and their operations in the global market.

Continue reading